Want to see HK:2197 full AI Analyst Report?
Clover Biopharmaceuticals Ltd. (2197) Financial Statements
Clover Biopharmaceuticals Ltd. Financial Overview
Clover Biopharmaceuticals Ltd.'s market cap is currently $1.62B. The company's EPS TTM is $0.66; its P/E ratio is 1.61; Clover Biopharmaceuticals Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.41M | $ 38.42M | $ 39.26M | $ 0.00 | $ 0.00 |
| Gross Profit | $ -23.85M | $ -672.94M | $ 24.24M | $ -475.64M | $ -66.27M |
| Operating Income | $ -247.75M | $ -951.21M | $ -2.58B | $ -2.35B | $ -2.24B |
| EBITDA | $ -221.24M | $ -914.52M | $ -45.07M | $ -2.34B | $ -2.21B |
| Net Income | $ -199.78M | $ -903.43M | $ -138.54M | $ -2.45B | $ -6.02B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 286.15M | $ 427.53M | $ 766.26M | $ 1.64B | $ 2.87B |
| Total Assets | $ 458.12M | $ 812.74M | $ 2.10B | $ 4.69B | $ 5.35B |
| Total Debt | $ 10.62M | $ 89.64M | $ 334.45M | $ 354.37M | $ 67.92M |
| Net Debt | $ -260.90M | $ -311.60M | $ -401.41M | $ -1.25B | $ -2.70B |
| Total Liabilities | $ 2.26B | $ 2.45B | $ 2.83B | $ 5.36B | $ 4.13B |
| Stockholders' Equity | $ -1.80B | $ -1.64B | $ -732.83M | $ -668.14M | $ 1.22B |
| Cash Flow | |||||
| Free Cash Flow | $ -190.55M | $ -290.11M | $ -737.05M | $ -1.80B | $ -998.07M |
| Operating Cash Flow | $ -190.52M | $ -288.49M | $ -727.88M | $ -1.69B | $ -917.75M |
| Investing Cash Flow | $ -11.69K | $ 3.17M | $ -6.16M | $ -37.51M | $ 112.12M |
| Financing Cash Flow | $ -76.59M | $ -51.50M | $ -142.41M | $ 483.14M | $ 3.06B |
Currency in CNY